Search results Search for: Search Refine your results by duration: Any Under 5 mins Under 20 mins Over 20 mins Sort by: Relevance Views Date Tipifarnib as a Precision Therapy for HRAS-Mutant Head and Neck SCCs Francis Burrows, PhD, VP of Translational Research, Kura Oncology Tipifarnib is a potent and highly selective inhibitor of farnesyltransferase (FT). FT catalyzes the post-translational attachment of farnesyl grou... 1 year ago | 43 mins Knowing the Business: Medicine for Managers, Cancer Webinar Sue Robinson, Deputy Director of Finance and Nick Slevin A joint presentation with a finance director and clinician Professor Slevin, Head and Neck Clinical Oncologist at The Christie NHS Foundation Trust. 8 years ago | 64 mins
